Genetic and transcriptional evolution alters cancer cell line drug response
2018 · Nature · 890 citations
https://doi.org/10.1038/s41586-018-0409-3
K
Kunihiko Hinohara
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
3.7K
Citations
26
h-index
40
i10-index
Kunihiko Hinohara is an academic researcher from Center for Disease Dynamics, Economics & Policy. The author has contributed to research in topics: RNA modifications and cancer & Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses. The author has an h-index of 26, co-authored 80 publications.
ORCID: 0000-0002-7099-9441Papers by this author
worksMUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer
2017 · Cancer Research · 264 citations
https://doi.org/10.1158/0008-5472.can-17-1636
ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer
2012 · Proceedings of the National Academy of Sciences · 100 citations
https://doi.org/10.1073/pnas.1113271109
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
2019 · Nature Communications · 51 citations
https://doi.org/10.1038/s41467-019-12125-5
MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors
2016 · Scientific Reports · 44 citations
https://doi.org/10.1038/srep26643
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state
2023 · Nature Communications · 31 citations
https://doi.org/10.1038/s41467-023-44081-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat